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1 Extracellular adenosine 5'-triphosphate (ATP) activated an early excitatory conductance followed by a
late potassium conductance in developing chick skeletal muscle. A series of ATP analogues were tested for
their ability to activate these two conductances. All compounds tested were either agonists for both
responses or for neither. Furthermore, the potency of agonists was similar for the two responses.
2 The order of potency for agonists was ATP z adenosine 5'-O-(3-thiotriphosphate) (ATP-y-S) 2-
methylthio-ATP (2-CH3S-ATP) > 2'-deoxy-ATP - 3'-deoxy-ATP > adenosine 5'-tetraphosphate (ATP-
OP03) adenosine 5'-diphosphate (ADP). Many other ATP analogues were not agonists.
3 Activation of the excitatory response did not require divalent cations. Furthermore, the concentration-
response relation of the excitatory response was similar when ATP was applied as the free anion of ATP
(ATP4-) or complexed with a divalent cation (M * ATP2-).
4 Three antagonists of the ATP response were characterized. 8-Br-ATP was a weak antagonist, while
2',3'-dialdehyde-ATP and DIDS (4,4'-diisocyanatostilbene-2,2'-disulphonic acid) were potent irreversible
inhibitors. The two conductances were equally affected by these antagonists.
5 These results suggest that both ATP responses are activated through the same receptor type, or two
very similar receptors.
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Introduction
Extracellular adenosine 5'-triphosphate (ATP) is known to
activate a variety of cellular responses in many different
tissues (Gorden, 1986). For example, there is good evidence
suggesting that ATP participates in synaptic transmission
from autonomic neurones to smooth muscle cells (Burnstock,
1981). ATP is packaged in cholinergic vesicles (Zimmermann,
1982), and released upon stimulation of motor neurones
(Silinsky & Hubbard, 1973), so ATP receptors could poten-
tially play a role in synaptic transmission at the skeletal
neuromuscular junction. In developing chick skeletal muscle
in culture, micromolat concentrations of extracellular ATP
activate an early excitatory conductance followed by a late
potassium conductance (Hume & Thomas, 1988). To test
whether these two responses are activated by different recep-
tor types, a variety of ATP analogues were screened for their
ability to activate or inhibit these two responses, and the
potencies of those analogues that were agonists were com-
pared. This study also allowed us to evaluate systematically
the effect of various alterations to the structure of ATP on the
ability to activate responses. Our results are consistent with
the possibility that both ATP responses are activated by the
same receptor type. In addition, two antagonists which may
prove useful in determining the function of the ATP receptor
and in identifying the macromolecule(s) that constitute this
receptor have been characterized.
Methods
Cell culture
Standard chick embryo muscle cell cultures were prepared as
described previously (Hume & Honig, 1986). Briefly, pectoral
muscle was dissected from 11 day old chick embryos, minced,
and incubated in a calcium- and magnesium-free saline
(Puck's saline) for 20 min at room temperature. The tissue was
then spun down for 5 min, resuspended in culture medium,
and triturated until the solution was cloudy. Cell density was
determined with a haemocytometer after the suspension was
filtered through lens paper to remove debris. To prepare
myotube cultures, cells were plated onto gelatin-coated tissue
culture dishes (Corning) at 150,000 per 35mm dish. Myoballs
(spherical, multinucleate muscle cells) were made in an identi-
cal manner up to the cell plating stage. Cells were preplated
onto uncoated tissue culture dishes at 750,000 per 35mm dish
and incubated at 370C for 2 to 3 h. This procedure greatly
reduced the number of fibroblasts, which adhere more rapidly
to the dishes than the muscle precursor cells. The culture
dishes were then swirled several times and the medium of each
dish (containing an enriched population of myoblasts) was
transferred to a fresh, uncoated tissue culture dish. The high
cell density promoted the formation of clusters of muscle pre-
cursor cells. The reduction in fibroblasts and the use of
uncoated dishes made the culture dish surface poorly adhe-
sive, which inhibited muscle cell elongation. Recordings were
made from myotubes after 6 to 10 days in culture, or from
myoballs after 3 to 6 days in culture.
The culture medium, Eagle's minimum essential medium
(MEM) with Earle's salts (Gibco), was supplemented with
10% heat-inactivated horse serum (Gibco), penicillin/
streptomycin (50unitsml-', SOpggml-1) and conalbumin
(40,agml- 1, Sigma). Cultures were maintained in a humidified
incubator at 37°C with an atmosphere of 95% air, 5% CO2.
Solutions
Recording was performed over a period of up to several hours
at room temperature (21-23°C) without perfusion of the bath.
Just prior to recording, each culture dish was washed at least
three times over a period of 5 min with the appropriate exter-
nal solution (Table 1) to replace the incubating media. Each
wash exchanged about 3 ml. All solutions contained HEPES
(as buffer) and 30,M phenol red (as indicator) in order to
maintain the pH near 7.3. NaOH and KOH were used to
adjust the external and internal solutions respectively to pH
7.3.
The standard external solution contained cobalt, rather
than calcium, to prevent the secondary activation of the
calcium activated chloride current that is present in these cells
(Hume & Thomas, 1989). External solutions containing ethyl-
enediamine tetraacetate (EDTA) or ethyleneglycol-bis4-l-
aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA) were
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Table I Composition of solutions (in mM)
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used to examine the role of extracellular magnesium. The
EDTA solution was used to produce a solution essentially free
of magnesium, while the EGTA solution was used to set the
free magnesium concentration at different levels. The fraction
of total ATP that was not complexed with Mg2+ was calcu-
lated from the equation:
ATP4- = 1 -1/(I0x*[Mgfee])
where x = 4.2, the association constant of MgATP2- under
these conditions, and Mgfee was calculated assuming a Kd for
Mg2+ of 300pM (Walaas, 1958; Cockroft & Gomperts, 1979).
Intracellular and patch-clamp recording
Intracellular recordings were made with conventional glass
microelectrodes filled with 3MKCI as described previously
(Hume & Honig, 1986). The high input resistance of myotubes
bathed in the external solution allowed the membrane poten-
tial to be varied between + 20 and -I00mV by passing very
small currents (< 1 nA). The resistance of electrodes was
nearly constant when such small currents were passed; thus a
single microelectrode with a balanced bridge circuit was used
both to record voltage and pass current. The bridge circuit
was balanced just prior to penetration of each cell.
Standard techniques were employed to form high resistance
seals with pipettes onto the membrane of myoballs and to
gain access to the cell interior (Hamill et al., 1981). Myoballs
were dialyzed with the internal solution and bathed in one of
the external solutions (Table 1). Polished pipettes had resist-
ances of 2 to 4 MO, and recordings were made from myoballs
whose diameters ranged from 15 to 30,um.
Drugs
All compounds came from Sigma except for 2-methylthio-
ATP (2-CH3-S-ATP) (Research Biochemicals), adenosine
5'-O-(3-thiotriphosphate) (ATP-y-S) and fy-imido-ATP
(AMP-PNP) (Boehringer Mannheim). Agonists were dissolved
in the appropriate external solution and loaded into pipettes
having tip diameters of 2-4pm. Solution was ejected from the
pipettes by pressure applied to the back of the pipette. The
duration of the pressure pulse was accurately controlled by a
solenoid valve in the pressure line. When the solenoid closed,
it vented the pipette to the outside, so that no residual pres-
sure could continue to force drug from the pipette. The tip of
the pipette was placed approximately 30-60pm from the test
cell. The compounds used in this study, and the abbreviations
used were as follows: adenosine 5'-triphosphate (ATP), aden-
osine 5'-diphosphate (ADP), adenosine 5'-monophosphate
(AMP), inosine 5'-triphosphate (ITP), guanosine 5'-
triphosphate (GTP), uridine 5'-triphosphate (UTP), cytidine
5'-triphosphate (CTP), 2-methylthio-ATP (2-CH3-S-ATP), 8-
bromo-ATP (8-Br-ATP), 2'- and 3'-O-(4-benzoylbenzoyl)-ATP



















adenosine 5'-O-(3-thiotriphosphate) (ATP-y-S), oc,,-methylene-
ATP (AMP-CPP), #,y-methylene-ATP (AMP-PCP), fly-
imido-ATP (AMP-PNP), adenosine 5'-O-(3-thiotriphosphate)
(ADP-6-S), adenosine 5'-diphosphoramidate (ADP-#-NH2),
adenosine 5'-diphosphomorpholidate (ADP-,8-morpholidate),
adenosine 5'-monophosphomorpholidate (AMP-a-morpholi-
date), adenosine 5'-phosphosulphate (AMP-OS03), adenosine
5'-monophosphoramidate (AMP-a-NH2) P1,P2-di(adenosine
5')pyrophosphate (A-P2-A), P1,P3-di(adenosine 5')triphos-
phate (A-P3-A), P',P4-di(adenosine 5')tetraphosphate (A-P4-
A), P',P5-di(adenosine 5')pentaphosphate (A-P_-A), Pl'p6_
di(adenosine 5')hexaphosphate (A-P6-A), 2',3'-dialdehyde-




Measurement ofATP and analogue responsiveness
The responsiveness to ATP was measured in one of two ways.
Intracellular recordings from myotubes were used when
screening ATP analogues because many cells could be quickly
studied with this technique. Cells were initially adjusted to
-70 mV, and the input resistance (Ri.) was measured with a
0.1 nA hyperpolarizing current pulse. The peak depolarization
activated by a I s application of an agonist was measured, and
then divided by Rin to obtain an estimate for the current acti-
vated. For all agonists that activated an excitatory response, a
semi-quantitative concentration-response curve was prepared
by applying several different concentrations of agonist to a
series of myotubes. This method was quick, but produced only
a rough estimate of the parameters of the concentration-
response curve, because large responses are subject to con-
siderable non-linear summation. For this reason, EC50s
obtained by this method are reported only by their approx-
imate magnitude (Table 2), rather than as discrete values.
Quantitative estimates of ATP responsiveness were
obtained from whole-cell recordings made from cultured myo-
balls, since the ATP-evoked currents could be measured
directly. Myoballs were voltage-clamped at either -80mV for
measurement of the excitatory ATP-activated current, or at
+10mV for measurement of the potassium current activated
by ATP (see Figure 1). Cell capacitance was measured to
obtain an estimate for the surface area of the cell. The peak
current activated by a I s application of an agonist was mea-
sured, and then normalized to 100 pF of cell capacitance.
To obtain concentration-response curves, it was necessary
to record from a population of cells for each concentration of
each agonist. Data from 5 to 20 cells were averaged for each
concentration, and then at least four different concentrations
were studied for each agonist. It was not possible to obtain
concentration-response curves from individual cells because
both the excitatory and potassium currents show long-term














SKELETAL MUSCLE ATP RECEPTOR
Hume, 1990b). A sigmoid curve was fitted to the averaged
data by a least-squares non-linear regression programme
(SigmaPlot 4.0, Jandel Scientific). The bottom of the sigmoid
curve was held constant at 0, while the maximum, the EC50,
and the Hill slope were allowed to vary. To test whether a
single curve could describe the relationship between agonist
concentration and the amplitude of both ATP responses, the
method described by Motulsky & Ransnas (1987) was used.
After the data for the two responses to each agonist had been
individually fitted, the two data sets were pooled (after divid-
ing each individual response by the estimated maximal
response), and the F ratio calculated. The average curve was
considered to be an adequate fit to both data sets if P was
>0.05.
Results
Low micromolar concentrations of extracellular ATP had a
dual effect on developing chick skeletal muscle (Figure 1).
ATP caused excitation by activating a class of small conduc-
tance (0.3pS) ion channels through which both cations and
anions permeate (Thomas & Hume, 1990a). ATP also elicited
a potassium conductance that had a longer latency to activa-
tion than the excitatory conductance (Hume & Thomas,
1988). Concentration-response curves for the two currents
activated by ATP are shown in Figure 2. A single curve fitted
the data for both the excitatory and potassium responses.
To characterize the pharmacological specificity of the ATP
receptor that elicited the excitatory current, ATP analogues
substituted at several different positions were tested. The
structure of ATP, with key positions labelled, is shown in
Figure 3. Each analogue was tested with intracellular record-






Figure 1 Activation of two distinct currents in chick skeletal muscle
by ATP. Application of 1OpM ATP began at the time indicated by the
first dotted line, and continued throughout the traces. For each trace,
a horizontal dashed line indicates the holding current prior to the
application of ATP. When a myoball was held at -40mV (bottom
trace), a large inward current was elicited with a delay of only a few
milliseconds. After several seconds the current began to return
towards the baseline. This return to baseline represented the activa-
tion of a second current. The presence of the second current could be
seen more clearly when myoballs were held at more positive poten-
tials. At -20mV (middle trace) a biphasic current response was
observed; the net current elicited by ATP was first inward and then
outward. When a myoball was held at +10mV (top trace), the early
phase of the ATP response was absent, because the cell was at its
reversal potential. ATP elicited only an outward current with a delay
of several hundred milliseconds between the beginning of ATP appli-
cation and the beginning of the response (indicated by second dotted
line). At potentials positive to +lOmV (not shown), ATP evoked




Figure 2 Concentration-response curves for the two currents activat-
ed by ATP. The peak current was measured in response to applica-
tion of ATP from a nearby puffer pipette. Myoballs were
voltage-clamped at -80mV to isolate the excitatory current (U, thick
error bars), or at + 10mV to isolate the potassium current (0, thin
error bars). For each concentration of ATP, 5-20 cells were tested,
and the ATP evoked currents were normalized (to pA/100 pF) and
then averaged. To allow for presentation of concentration-response
data for both responses on a single set of axes, least squares fits to the
data for excitatory and potassium responses were performed separa-
tely. The average response and standard error for each concentration
of ATP were divided by the maximal current indicated by the fitted
curves. The solid line represents the least squares fit to the data for the
excitatory response. The parameters of this curve were EC50 = 6.6AM,
Hill coefficient = 1.5, maximal current = -1092 pA. Except for the
expected difference in the maximal current reached, the curve fitted to
the potassium current data was not significantly different (EC50=

















Figure 3 Primary structure of ATP, 2',3'-dialdehyde-ATP (oxidized
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to a potential of -70 mV. At least 10 fibres from two different
platings were tested for each analogue. The ability of ATP
analogues modified at various positions to elicit a depolar-
ization is summarized in Table 2.
Twenty six of the ATP analogues that were tested for their
ability to activate the excitatory response were also tested for
their ability to activate the potassium current. In these experi-
ments, myoballs were voltage clamped at +10mV, the
reversal potential for the excitatory response. The potassium
current had a pharmacological spectrum very similar to that
for the excitatory current; each of the fifteen analogues that
elicited the excitatory current also activated the potassium
current and each of the eleven analogues that failed to activate
the excitatory current also failed to activate the potassium
current. The concentration-response relationships for both
responses were examined semi-quantitatively for all 15 agon-
ists (Table 2) and quantitatively for 8 agonists covering a wide
spectrum of potencies (Table 3). For all agonists, there was
great similarity in the EC50 for the excitatory and potassium
currents activated by ATP. For 6 of the 8 agonists examined
in detail, statistical analysis indicated that a single, averaged
curve could describe the concentration-response relationship
for either response as well as the individual curves, but sta-
tistical analysis indicated that, at the 5% confidence level, the
best curves describing the two responses elicited by ATP-y-S
and by 3'-deoxy-ATP were not the same. One interpretation
of these results is that the excitatory and potassium currents
are activated by two distinct, but similar receptors. However,
this conclusion may be incorrect. In both of these cases, one of
the curves had a Hill coefficient that, based on the data for the
other agonists, was aberrant. If the fits were constrained to
have a Hill coefficient between 1 and 2, as suggested by the
bulk of the data for agonists of high potency, then the best
fitted curves for these two agonists were no longer signifi-
cantly different. For this reason, there is at present no com-
pelling reason to postulate that more than a single class of
ATP receptors is present on the surface of chick skeletal
muscle cells.
Table 2 Activity of ATP analogues





































To test whether an analogue was an agonist for the excitatory response, the analogue was pressure-ejected (at mm, except where
indicated by *, when 0.5mm was used) from a pipette for I s while recording the membrane potential from a nearby myotube. The initial
membrane potential of the myotube was adjusted to -70mV prior to application of an analogue. The analogue was scored as an agonist
if it produced a depolarization in several myotubes. For analogues that did not produce a response, we confirmed that the cells depolar-
ized in response to 10UM ATP. The potency of all agonists was estimated by use of intracellular recording methods. Because this method
was only semi-quantitative, EC50s are given only by their approximate magnitude, rather than as discrete values. The potency of a subset
of agonists was also assessed quantitatively by whole-cell recording (Table 3). Compounds indicated with an ! were also tested for their
ability to elicit potassium currents in myoballs voltage clamped to +lOmV. All compounds tested for activation of the potassium
current fell in the same potency class as indicated for the excitatory responses. For abbreviations, see Methods.
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For each agonist, data for concentration-response curves were collected and analyzed as described in Methods. This table presents the
parameters that best fitted the excitatory and potassium responses generated by each agonist. However, for 6 of the 8 agonists (indicated
by *), statistical analysis indicated that a single curve could describe both the excitatory and potassium responses as well as the individ-
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Figure 4 Inhibition of the two ATP responses by (a) 2',3'-
dialdehyde-ATP (oxidized ATP) and (b) 4,4'-diisothiocyanatostilbene-
2,2'-disulphonic acid (DIDS). Myoballs were incubated in the external
solution with the indicated concentration of inhibitor for 1 h at room
temperature prior to recording. The peak current activated by 50 M
ATP (applied from a pipette that did not contain the antagonist) was
measured. The cells were voltage-clamped at -80mV to study the
excitatory current (U, thick error bars) or at +10mV to study the
potassium current (0, thin error bars). The smooth curves represent
the curve fit to the data for the excitatory current. For oxidized ATP
(a), the best curve for inhibition of the excitatory response had an
IC50 of 9.4pM and a Hill slope of -1.3, while the best curve for inhi-
bition of the potassium conductance had an IC50 of 25AiM and a Hill
slope of -4.2. For DIDS (b), the best curve for inhibition of the excit-
atory response had an IC50 of 0.8 fM and a Hill slope of -2.6, while
the best curve for inhibition of the potassium conductance had an















Figure 5 Activation of the excitatory response by ATP4-. Myoballs
were voltage clamped at -80 mV. The data points illustrated were
taken from cells bathed in EDTA external, where virtually all the
ATP was in the form of ATP4-. The smooth curve is the one that was
fitted to cells bathed in normal external solution, where virtually all
the ATP was in the form of M ATP2-. The curves were normalized
to a single set of axes by assuming that the maximal current in these
experiments was -295 pA/I00pF.
All analogues that were not agonists were tested as poten-
tial antagonists by adding the analogue (at 0.5mM) to the
external solution in the bath and to the solution in the pipette
used to apply ATP. For these experiments, a concentration of
101UM ATP was used, because it was in the steep region of the
concentration-response curve, and thus would be most sensi-
tive to antagonist activity.
Only two classes of ATP analogues were found to be
antagonists. They were selective, since they did not inhibit the
response of muscle cells to 10 M acetylcholine. At a concen-
tration of 0.5mm, 8-Br-ATP reduced the response to 10pM
ATP and eliminated the response to 2 fiM ATP. The tri-
phosphate group was required for antagonism; neither 8-Br-
ADP nor 8-Br-AMP were effective antagonists at 0.5 mm.
Because it had to be present at high concentration to block
the response to ATP, the antagonism by 8-Br-ATP was not
analyzed in detail. A much more potent antagonist was the
periodate-oxidized analogue of ATP: 2',3'-dialdehyde-ATP
(oxidized ATP). Inhibition by this molecule was both time-
and temperature-dependent. With 100pM oxidized ATP,
almost complete antagonism developed in about 30min at
room temperature, and it developed more rapidly at 370C.
Inhibition could not be overcome with higher concentrations
of ATP, and block was still effective after washing out the
external solution containing oxidized ATP.
Approximately half of either the excitatory or the potassium
conductance activated by ATP could be blocked by 10pUM oxi-
dized ATP (Figure 4).
Interestingly, although ADP and AMP were much less
potent agonists than ATP, oxidized ADP and oxidized AMP
were as potent as oxidized ATP at blocking the response to
ATP. However, oxidized adenosine had no effect on the ATP
response. In addition, the oxidized forms of a number of
nucleotide triphosphates that had no agonist activity (ITP,
GTP, UTP, and CTP) blocked the response to ATP in a
similar manner. However, these compounds required more
time to be effective. For example, when a 1 h incubation at
room temperature was used, these compounds were less effec-
tive than oxidized ATP, but they were almost as effective as
oxidized ATP after a 1 h incubation at 370C.
McMillian et al. (1988) reported that the stilbene derivative
DIDS (4,4'-diisothiocyanatostilbene 2,2'-disulphonic acid) was
a selective blocker of the ATP-induced increase in intracellu-
lar free calcium in rat parotid acinar cells. In chick skeletal
muscle, DIDS was an even more potent antagonist of the
ATP response than any of the ATP analogues tested. DIDS
was similar to oxidized ATP in that its block was both time-
and temperature-dependent, and could not be overcome with
higher concentrations of ATP. Complete block of both con-
ductances activated by ATP was observed with 20pM DIDS,
while approximately 1 glM DIDS was required to block half of
each response (Figure 4). The related stilbene derivative SITS
(4-acetamido-4'-isothiocyanatostilbene 2,2'-disulphonic acid)
was approximately ten fold less potent in blocking the ATP
response.
Activation: A TP4- versus MgATP2-
In a solution which contains divalent cations, the free anion
ATP4- is in equilibrium with M ATP2-, where M rep-
resents a divalent cation. One class of ATP receptors is known
to be much more sensitive to ATP4- than to M ATP2-
(Cockroft & Gomperts, 1979). Two sets of experiments were
performed to evaluate the relative importance of ATP4 - and
M ATP2-. In one set of experiments, the total concentration
of ATP was kept constant at 5pM, but the ratio of ATP4- to
Mg- ATP2- was varied by adding differing amounts of mag-
nesium to solutions buffered with 11 mm EGTA. For the con-
centrations of total magnesium used, the free magnesium
concentration varied from 36pM to almost 1 mm, which pro-
duced concentrations of ATP4- from 0.3 to 3.2pm. Over this
ten fold range of ATP4-, the magnitude of the responses to
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myotubes) remained essentially constant (0.3 4UM,
-312+38pA; 1.7pM, - 349+91pA; 3.2AM, -235+25
pA). This result indicated either that the receptor for the excit-
atory response does not distinguish between ATP4 - and
Mg * ATP2-, or that 0.3 pM ATP4- is a saturating concentra-
tion. To test the latter possibility, cells were exposed to a solu-
tion containing 5mM EDTA, without adding any divalent
cations. In this solution ATP is almost entirely in its free
anion form, ATP4-. When myoballs were bathed in this solu-
tion and held at -80mV, inward currents were activated by
ATP over a concentration-range similar to that in the stan-
dard external solution, and the concentration-response
relationship was not significantly different from that for ATP
in normal external solution (Figure 5). Thus the receptor for
ATP does not appear to discriminate between ATP4- and
M ATP2-, nor does it require divalent cations for activa-
tion.
Discussion
ATP activates an excitatory conductance and a potassium
conductance in developing chick skeletal muscle (Hume &
Thomas, 1988). In the work described here, a series of ATP
analogues was tested for their ability to activate these two
responses. We found that the same set of analogues activated
each conductance. Furthermore, the concentration-response
relationship for each agonist was similar for the two
responses. These results are consistent with the possibility that
the two responses are activated by one receptor type for
ATP, rather than by two distinct receptor subtypes.
There are at least three mechanisms by which a single
receptor class could activate two distinct responses. One
possibility is that activation of the second response is a conse-
quence of activation of the excitatory response. For instance,
calcium ions might flow into the cells during the early
response and activate a calcium-dependent potassium current.
However, this particular explanation cannot be correct, since
the potassium current can be evoked in the absence of extra-
cellular calcium. Recordings from cell-attached patches and
excised outside-out patches indicate that the potassium
current is activated by a diffusible second messenger and
suggest that this messenger is not responsible for activation of
the excitatory response (Hume & Thomas, 1990). Therefore, a
second possibility is that binding of ATP to its receptor pro-
duces two different second messengers, one capable of only
limited diffusion, which activates the excitatory response, and
a second that can diffuse longer distances to activate the pot-
assium current. A third possibility is that the ATP receptor is
part of a molecular complex that comprises both an ion
channel and an enzymatic activity that produces the second
messenger that activates the potassium current. This third sce-
nario is consistent with the observation that the excitatory
current can be activated within a few milliseconds of applica-
tion of ATP (Hume & Thomas, 1988). Finally, it is possible
that there are two distinct, but very similar ATP receptors,
one of which is coupled to the excitatory channel and the
other coupled to the production of a second messenger.
The specificity ofATP
The receptor for ATP is relatively specific. ADP was about 20
times less potent as an agonist while AMP and adenosine
were ineffective. Other nucleotide triphosphates were unable
to activate the responses to ATP. Thus most if not all stimu-
lation of this receptor in vivo probably results from exposure
to ATP. Since most of the agonists had Hill slopes between 1
and 2, it seems likely that the receptor must bind 2 molecules
of ATP to be activated.
By comparing the potency of the various analogues, one
can learn what sites of the ATP molecule are important for
activation of the receptor. The effect of modifying the adenine
base of ATP depended on the site of modification. At least
several sites of the adenine moiety appear to be responsible for
nucleotide-specific recognition. These include N1 and the
amino group of C6. Oxidation of the N1 nitrogen created a
low potency agonist. Reaction of ethene with N1 and the
amino group of C6, which created a third ring, eliminated
agonist activity. ITP, which is identical to ATP except that the
amino group of C6 is replaced by a carbonyl oxygen, was also
ineffective. The area around C2 seems to be relatively unim-
portant since the addition of a methylthio group to this
carbon did not reduce potency. Additions to C2 force ATP to
stay in the 'anti' conformation, in which the base points away
from the phosphates so that the molecule is fully extended (as
shown schematically in Figure 3). In contrast, the addition of
bromide to C8 forces ATP to adopt the 'syn' conformation
almost exclusively (the base points in the direction of the
phosphates, so the molecule looks like a U). This addition
eliminated agonist activity and instead produced an antago-
nist, suggesting that the 'anti' conformation is required for
activation.
There also appeared to be important interaction sites
between the receptor and the ribose of ATP. Both 2'- and
3'-deoxy-ATP were ten fold less potent than ATP as agonists.
Interestingly, when these two sites were oxidized to aldehydes,
the analogue became a fairly potent irreversible antagonist.
These results suggest that normally the hydroxyls of the ribose
hydrogen-bond to sites in the receptor. These sites might react
to form a covalent bond when brought next to an aldehyde.
When the aldehydes of oxidized ATP were reduced to alco-
hols, no antagonism was observed, demonstrating the impor-
tance of these aldehydes to antagonism. The lack of specificity
for adenine as the base of the oxidized nucleotide, and the
requirement that the nucleotide be only a monophosphate to
block the response, suggests that the minimal molecular unit
for an antagonist might be simply oxidized ribose 5'-
monophosphate.
With respect to activation, the length of the phosphate
chain was critical. Adenosine tetraphosphate and ADP were
approximately ten fold less potent than ATP, and AMP and
adenosine were without effect. Of the agonists tested, all modi-
fications to the # phosphorous of ADP eliminated agonist
activity. This may have been for steric reasons when large
groups such as glucose or adenosine were added. However,
the lack of any agonist activity with ADP-f,-S and ADP-/J-
NH2 in contrast to ADP suggests that the oxygen atoms in
the second phosphate group may be important for activation.
On the other hand, ATP-y-S was as potent an agonist as ATP,
indicating that the oxygens of the third phosphate are less
crucial than those of the second. The two oxygens linking the
three phosphates of ATP together must be important, since
replacing them with either carbon or nitrogen lowered agonist
potency dramatically. The di-adenosine phosphates (with the
exception of the diphosphate) were low potency agonists. As
might be expected for two separate sites of interaction
between the receptor and ATP, combining two modifications
that partially reduced the potency resulted in an analogue that
was inactive (2'-deoxy-ADP).
Classification ofATP receptors on skeletal muscle
Since ATP but not adenosine is an agonist, then by definition
the receptors must be in the second class of purinoceptors (P2)
(Burnstock, 1981). P2 receptors have been broken down into
several subtypes: T, X, Y, Z. The T and Z receptors have been
described in circulating and immune cells, while X and Y have
been found in smooth muscle, endothelium, liver, pancreas
and parotid acinar cells (Gorden, 1986). The receptors on
chick skeletal muscle do not meet the established criteria for
belonging to any of these classes. The criteria for assigning a
receptor to the P2X class are that 2-CH3S-ATP is approx-
imately equipotent to ATP, (as was observed in chick skeletal
muscle) and that AMP-PNP and AMP-PCP are more potent
than ATP (contrary to what was observed in chick skeletal
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muscle). The criteria for assigning a receptor to the P2Y or P2T
classes are that AMP-PNP and AMP-PCP are less potent
than ATP (as was observed in chick skeletal muscle) and that
2-CH3S-ATP is more potent than ATP (unlike chick skeletal
muscle). In addition, the P2T receptor responds to ADP as
well as or better than ATP (unlike what was observed for
chick skeletal muscle). Finally, the criteria for assigning a
receptor to the P2Z class are that the responses are largely or
exclusively to ATP4-, and that 2'/3'-BB-ATP is a more potent
agonist than ATP. Both of these criteria are contrary to the
results obtained for chick skeletal muscle.
The pharmacology of the chick skeletal muscle receptor
appears to be most closely related to that described for
cardiac muscle. ATP activates a small conductance cation
channel in frog atrial myocytes (Friel & Bean, 1988), and
increases intracellular free calcium in rat ventricular myocytes
(De Young & Scarpa, 1987). The only pharmacological differ-
ences were that ADP was not effective at 100-200puM, ATP-y-
S was slightly less potent than ATP, and AMP-CPP was an
antagonist in frog cardiac muscle. ATP also activates a cation
channel in arterial smooth muscle, but this receptor probably
falls under the P2X subtype since AMP-CPP was equipotent
with ATP (Benham & Tsien, 1987).
ATP also elicits excitatory responses from several neuronal
cell types. ATP activates cation channels in rat sensory neu-
rones of spinal cord and brainstem ganglia (Krishtal et al.,
1983; 1988). These receptors have a similar pharmacology to
that in chick skeletal muscle. However, for other neuronal
ATP receptors the pharmacology is quite different. In the
central nervous system, a subpopulation of dorsal horn neu-
rones are excited by ATP. However, excitation is also elicited
by AMP-PNP and AMP-PCP, suggesting that this receptor is
of the P2X subtype (Jahr & Jessel, 1983). A much less specific
excitatory response is seen in bullfrog sympathetic neurones,
where most nucleotide triphosphates are effective (Siggins et
al., 1977).
Finally, it has been shown that ATP stimulates the pro-
duction of inositol phosphates in chick skeletal muscle
(Haggblad & Heilbronn, 1987). However, the reported speci-
ficity of this response is different from what we have described
for channel activation. Production of inositol phosphates is
reported to be stimulated equally well by ATP and AMP-
PNP, and less potently by AMP and adenosine. These results
seem to suggest the possibility of two receptor subtypes for
ATP in chick skeletal muscle. The alternative hypothesis is
that activation of only a small number of receptors by
AMP-PNP is sufficient to produce a significant increase in
inositol phosphates, but not an electrical response. It would
be interesting to test whether oxidized ATP or DIDS blocked
the accumulation of inositol phosphates by ATP.
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